2817-45-0 Usage
General Description
Phosphoramidic acid is a chemical compound with the molecular formula H4NO3P. It is a member of the class of compounds known as phosphoramidic acids. It can be synthesized through the hydration of phosphonitrilic chloride. It possesses a significant reactivity towards hydroxyl groups which gives it the capability for usage in various chemical reactions and applications. However, it's not extensively used, potentially due to difficulties in its synthesis or issues related to stability. Phosphoramidic acid can also be potentially harmful if not handled with caution as it can cause skin irritations or serious eye damage.
Check Digit Verification of cas no
The CAS Registry Mumber 2817-45-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,8,1 and 7 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 2817-45:
(6*2)+(5*8)+(4*1)+(3*7)+(2*4)+(1*5)=90
90 % 10 = 0
So 2817-45-0 is a valid CAS Registry Number.
InChI:InChI=1/H4NO3P/c1-5(2,3)4/h(H4,1,2,3,4)
2817-45-0Relevant articles and documents
Phosphonamide ACAT inhibitors
-
, (2008/06/13)
The present invention is directed to compounds useful for the regulation of cholesterol of Formula I, methods for using them and pharmaceutical compositions thereof, STR1 wherein Ar and Ar1 are each independently selected from unsubstituted or substituted phenyl which substituents are from 1-5 in number and are each independently selected from alkyl, alkoxy, hydroxy, halogen, nitro, trifluoromethyl, COOH, and COOalkyl; X is --NH--, --O--, --S--, or --(CH2)0-4 --, and R is hydrogen, alkyl, or phenyl.
Acylation products of bis(2-imidazolin-2-ylhydrazones) of 9,10-anthracenedicarboxaldehyde
-
, (2008/06/13)
N-acylated derivatives of bis(2-imidazolin-2-ylhydrazones) of 9,10-anthracenedicarboxaldehyde, useful as anti-cancer agents against certain strains in mice, are disclosed and described, including processes for manufacture and use.
